| Literature DB >> 35997928 |
Lang Yu1,2,3, Wenhui Li1,2,3, Ge Lv1,2,3, Gan Sun1,2,3, Lu Yang1,2,3, Junjie Chen1,2,3, Lina Zhou1,2,3, Yuan Ding1,2,3, Zhiyong Zhang1,2,3,4, Xuemei Tang1,2,3,4, Yunfei An1,2,3,4, Xiaodong Zhao5,6,7.
Abstract
Chronic granulomatosis disease (CGD) is a rare inborn error of immunity, characterized by phagocytic respiratory outbreak dysfunction. Mutations causing CGD occur in CYBB on the X chromosome and in the autosomal genes CYBA, NCF1, NCF2, NCF4, RAC2, and CYBC1. Nevertheless, some patients are clinically diagnosed with CGD, due to abnormal respiratory outbursts, while the pathogenic gene mutation is unidentified. Here, we report a patient with CGD who first presented with Bacillus Calmette-Guérin disease and had recurrent pneumonia. He was diagnosed with CGD by nitro blue tetrazolium and respiratory burst tests. Detailed assessment of neutrophil activity revealed that patient neutrophils were almost entirely nonfunctional. Sanger sequencing detected a 6-kb insertion of a LINE-1 transposable element in the third intron of CYBB, leading to abnormal splicing and pseudoexon insertion, as well as introduction of a premature termination codon, resulting in predicted protein truncation. Clonal analysis demonstrated that the patient had somatic mosaicism, and the phagocytes were almost all variant CYBB, while the mosaicism rate of PBMC was about 65%. Finally, deep RNA sequencing and gp91phox expression analysis confirmed the pathogenicity of the mutation. In conclusion, we demonstrate that insertion of a LINE-1 transposon in a CYBB intron was responsible for CGD in our patient. Intron LINE-1 transposon element insertion should be examined in CGD patients without any known disease-causing gene mutation, in addition to identification of new genes.Entities:
Keywords: CYBB; LINE-1; chronic granulomatous disease; de novo; insertion; somatic mosaicism
Year: 2022 PMID: 35997928 DOI: 10.1007/s10875-022-01347-w
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.542